---
title: "Amgen touched record high after-hours following strong Q2 earnings, multiple target price hikes"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296531510.md"
description: "Amgen hit a record high after-hours after reporting Q2 EPS of $6.29, beating estimates. Multiple banks raised price targets above $450."
datetime: "2026-08-20T20:10:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296531510.md)
  - [en](https://longbridge.com/en/news/296531510.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296531510.md)
generator: "portal-rs"
---

# Amgen touched record high after-hours following strong Q2 earnings, multiple target price hikes

安进 (AMGN.US) 盘后交投于 433.73 美元，较前一交易日收盘价持平，此前在常规交易中录得**1.95%**跌幅。该股在盘后交易中价格区间为**433.73**至**435.913**美元，盘中触及历史新高。

消息面方面，安进近期公布强劲二季度业绩，每股收益**6.29 美元**超出市场预期，营收同比增长**9.5%**。公司宣布每股季度股息**2.52 美元**，并上调全年业绩指引。多家投行近期上调安进目标价，其中 TD Cowen 将目标价从**420 美元**上调至**452 美元**，BMO 设定**450 美元**目标价，Argus 将目标价从**375 美元**上调至**460 美元**并维持「买入」评级。

机构持仓方面，多只基金在二季度增持安进股票，包括 Main Street Financial Solutions 新建仓**166 万美元**、Simplicity Wealth 增持**122.5%**至**380 万美元**、Bridgewater Advisors 增持**114.5%**至**206 万美元**。与此同时，Danske Bank 减持**6.8%**，Abner Herrman & Brock 减持**24.1%**。

行业层面，Moderna 与默沙东联合开发的癌症疫苗在三期临床试验中取得突破，带动生物科技板块整体走强。安进作为大型制药企业之一受益于板块轮动情绪。此外，公司核心产品 MariTide 在肥胖症管理的二/三期临床数据积极，被视为潜在增长驱动力。

### Related Stocks

- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)

## Related News & Research

- [UK regulator suspends Amgen's Tavneos for new patients over unreliable data](https://longbridge.com/en/news/297642592.md)
- [Amgen Inc. (NASDAQ:AMGN) Given Consensus Rating of "Hold" by Brokerages](https://longbridge.com/en/news/297390790.md)
- [Strait & Sound Wealth Management LLC Invests $1.92 Million in Amgen Inc. $AMGN](https://longbridge.com/en/news/297400046.md)
- [8,321 Shares in Amgen Inc. $AMGN Bought by Glenview Trust Co](https://longbridge.com/en/news/297400065.md)
- [Beacon Pointe Advisors LLC Acquires New Position in Amgen Inc. $AMGN](https://longbridge.com/en/news/297394245.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**